Literature DB >> 8839829

Mycosis fungoides and Sezary syndrome.

E Diamandidou1, P R Cohen, R Kurzrock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839829

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  28 in total

1.  Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy.

Authors:  Michael Nebozhyn; Andrey Loboda; Laszlo Kari; Alain H Rook; Eric C Vonderheid; Stuart Lessin; Carole Berger; Richard Edelson; Calen Nichols; Malik Yousef; Lalitha Gudipati; Meiling Shang; Michael K Showe; Louise C Showe
Journal:  Blood       Date:  2006-01-10       Impact factor: 22.113

2.  Successful cord blood transplantation for mycosis fungoides.

Authors:  Takuya Fukushima; Kensuke Horio; Emi Matsuo; Daisuke Imanishi; Reishi Yamasaki; Hideki Tsushima; Yoshitaka Imaizumi; Koichi Ohshima; Tomoko Hata; Shinichiro Yoshida; Yasushi Miyazaki; Masao Tomonaga
Journal:  Int J Hematol       Date:  2008-11-08       Impact factor: 2.490

Review 3.  NFκB function and regulation in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

4.  The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.

Authors:  Michael J Kelly-Sell; Youn H Kim; Suzanne Straus; Bernice Benoit; Cameron Harrison; Katherine Sutherland; Randall Armstrong; Wen-Kai Weng; Louise C Showe; Maria Wysocka; Alain H Rook
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

5.  Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma.

Authors:  Maria Wysocka; Noor Dawany; Bernice Benoit; Andrew V Kossenkov; Andrea B Troxel; Joel M Gelfand; Michael Kelly Sell; Louise C Showe; Alain H Rook
Journal:  Leuk Lymphoma       Date:  2011-10

Review 6.  The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

Authors:  Ercole Mazzeo; Laura Rubino; Michela Buglione; Paolo Antognoni; Stefano Maria Magrini; Francesco Bertoni; Manuela Parmiggiani; Paola Barbieri; Filippo Bertoni
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-13

7.  Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.

Authors:  Larisa J Geskin; Sara Viragova; Donna B Stolz; Patrizia Fuschiotti
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

8.  Response to hydralazine-valproate in a patient with mycosis fungoides.

Authors:  Alfonso Dueñas-Gonzalez; Maria Teresa Vega; Déborah Martinez-Baños; Linda García-Hidalgo; Pedro Sobrevilla
Journal:  Case Rep Med       Date:  2010-03-21

Review 9.  Review of the treatment of mycosis fungoides and Sézary syndrome: A stage-based approach.

Authors:  Ghadah I Al Hothali
Journal:  Int J Health Sci (Qassim)       Date:  2013-06

10.  Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma.

Authors:  H Bachelez; F Hadida; C Parizot; B Flageul; M Kemula; L Dubertret; P Debree; G Gorochov
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.